IN2014CN03903A - - Google Patents
Download PDFInfo
- Publication number
- IN2014CN03903A IN2014CN03903A IN3903CHN2014A IN2014CN03903A IN 2014CN03903 A IN2014CN03903 A IN 2014CN03903A IN 3903CHN2014 A IN3903CHN2014 A IN 3903CHN2014A IN 2014CN03903 A IN2014CN03903 A IN 2014CN03903A
- Authority
- IN
- India
- Prior art keywords
- glucocorticoid
- pharmaceutical compositions
- relates
- mineralocorticoid
- pregenen
- Prior art date
Links
- 102000003676 Glucocorticoid Receptors Human genes 0.000 abstract 2
- 108090000079 Glucocorticoid Receptors Proteins 0.000 abstract 2
- 108090000375 Mineralocorticoid Receptors Proteins 0.000 abstract 2
- 239000003862 glucocorticoid Substances 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 102000003979 Mineralocorticoid Receptors Human genes 0.000 abstract 1
- 102100021316 Mineralocorticoid receptor Human genes 0.000 abstract 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to novel 4 pregenen 11 17 21 triol 3 20 dione derivatives processes for preparing them pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of glucocorticoid or mineralocorticoid receptors. The invention relates specifically to the use of these compounds and their pharmaceutical compositions to treat disorders associated with glucocorticoid or mineralocorticoid receptor modulation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161558775P | 2011-11-11 | 2011-11-11 | |
PCT/US2012/064293 WO2013071009A1 (en) | 2011-11-11 | 2012-11-09 | 4 - pregenen- 11ss - 17 - 21 -triol-3, 20 -dione derivatives for the treatment of ocular conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014CN03903A true IN2014CN03903A (en) | 2015-10-16 |
Family
ID=47179019
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3903CHN2014 IN2014CN03903A (en) | 2011-11-11 | 2012-11-09 | |
IN3919CHN2014 IN2014CN03919A (en) | 2011-11-11 | 2012-11-09 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3919CHN2014 IN2014CN03919A (en) | 2011-11-11 | 2012-11-09 |
Country Status (24)
Country | Link |
---|---|
US (7) | US8865691B2 (en) |
EP (2) | EP2776040B1 (en) |
JP (2) | JP6158201B2 (en) |
KR (2) | KR20140095549A (en) |
CN (2) | CN104203247B (en) |
AR (1) | AR088846A1 (en) |
AU (3) | AU2012335590B2 (en) |
BR (2) | BR112014011341A2 (en) |
CA (3) | CA2855929C (en) |
CL (2) | CL2014001244A1 (en) |
CO (2) | CO6970598A2 (en) |
ES (1) | ES2806603T3 (en) |
HK (2) | HK1200367A1 (en) |
IL (2) | IL232535B (en) |
IN (2) | IN2014CN03903A (en) |
MX (3) | MX365859B (en) |
MY (2) | MY172227A (en) |
PH (2) | PH12014501079B1 (en) |
RU (2) | RU2688159C2 (en) |
SG (3) | SG10201603766PA (en) |
TW (1) | TWI584809B (en) |
UA (2) | UA111867C2 (en) |
WO (2) | WO2013071009A1 (en) |
ZA (2) | ZA201403431B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2386555A1 (en) | 2010-05-13 | 2011-11-16 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities |
UA111867C2 (en) | 2011-11-11 | 2016-06-24 | Аллерган, Інк. | PHARMACEUTICAL COMPOSITION AND METHOD OF APPLICATION OF 4-PROGEN-11β-17-21-TRIOL-3,20-DION DERIVATIVES |
EP2592078A1 (en) | 2011-11-11 | 2013-05-15 | Almirall, S.A. | New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities |
EA201500651A1 (en) | 2012-12-18 | 2015-11-30 | Альмираль, С.А. | NEW DERIVATIVES AND cyclohexyl- HINUKLIDINILKARBAMATA having agonistic activity towards β2 adrenergic receptor and antagonistic activity against muscarinic receptors M3 |
TWI643853B (en) | 2013-02-27 | 2018-12-11 | 阿爾米雷爾有限公司 | SALTS OF 2-AMINO-1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2(1H)-ONE DERIVATIVES HAVING BOTH β2 ADRENERGIC RECEPTOR AGONIST AND M3 MUSCARINIC RECEPTOR ANTAGONIST ACTIVITIES |
TW201517906A (en) | 2013-07-25 | 2015-05-16 | Almirall Sa | Combinations comprising MABA compounds and corticosteroids |
TWI641373B (en) | 2013-07-25 | 2018-11-21 | 阿爾米雷爾有限公司 | SALTS OF 2-AMINO-1-HYDROXYETHYL-8-HYDROXYQUINOLIN-2(1H)-ONE DERIVATIVES HAVING BOTH MUSCARINIC RECEPTOR ANTAGONIST AND β2 ADRENERGIC RECEPTOR AGONIST ACTIVITIES |
AR098747A1 (en) * | 2013-12-13 | 2016-06-08 | Allergan Inc | POLYMORPHIC FORMS OF A STEROID SIMILAR COMPOUND AND METHODS FOR PREPARATION AND USE |
TW201617343A (en) | 2014-09-26 | 2016-05-16 | 阿爾米雷爾有限公司 | New bicyclic derivatives having [beta]2 adrenergic agonist and M3 muscarinic antagonist activities |
RU2746083C2 (en) * | 2015-03-05 | 2021-04-06 | Аллерган, Инк. | Self-emulsing drug delivery systems (sedds) for ophthalmic medicine delivery |
CA3037176A1 (en) * | 2016-09-16 | 2018-03-22 | Kala Pharmaceuticals, Inc. | Particles, compositions, and methods for ophthalmic and/or other applications |
WO2019055028A1 (en) * | 2017-09-15 | 2019-03-21 | Kala Pharmaceuticals, Inc. | Particles, compositions, and methods for ophthalmic and/or other applications |
CN116023425B (en) * | 2023-03-28 | 2023-06-20 | 南京师范大学 | Triamcinolone derivatives and medical application thereof |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL6605514A (en) * | 1966-04-25 | 1967-10-26 | ||
IT1056711B (en) * | 1967-04-01 | 1982-02-20 | Vismara F Spa | DERIVATIVES OF HYDROCORTISONE |
US3484436A (en) * | 1967-09-07 | 1969-12-16 | Syntex Corp | Bicyclo(2.2.2)octane - 1 - -carboxylate esters of delta**4 - pregnene corticoid steroids |
GB1227992A (en) | 1968-01-23 | 1971-04-15 | Koninklijke Gist Spiritus | |
US3693032A (en) | 1971-04-23 | 1972-09-19 | Ibm | Antisaturation technique for ttl circuits |
US3984544A (en) * | 1975-02-28 | 1976-10-05 | Schering Corporation | Retinoic acid esters of steroids of the pregnane series, their use in the treatment of acne and pharmaceutical formulations useful therefor |
JPS52136157A (en) * | 1976-04-14 | 1977-11-14 | Taisho Pharmaceut Co Ltd | Preparation of steroid 17-esters |
JPS60994B2 (en) * | 1976-07-26 | 1985-01-11 | 大正製薬株式会社 | Method for producing 17α-esters of pregnane compounds |
DE2735110A1 (en) * | 1977-08-04 | 1979-02-15 | Hoechst Ag | CORTICOID-17-ALKYLCARBONATE AND METHOD FOR THE PRODUCTION THEREOF |
US4221787A (en) * | 1978-03-28 | 1980-09-09 | Interx Research Corporation | Esteramide prodrugs of anti-inflammatory corticosteroids |
US4221778A (en) * | 1979-01-08 | 1980-09-09 | Pennwalt Corporation | Prolonged release pharmaceutical preparations |
DE4025342A1 (en) | 1990-08-10 | 1992-02-13 | Hoechst Ag | CORTICOID-17-ALKYLCARBONATE SUBSTITUTED IN 17-POSITION, METHOD FOR THE PRODUCTION THEREOF, AND MEDICINAL PRODUCTS CONTAINING THE SAME |
US6011023A (en) * | 1997-08-27 | 2000-01-04 | Alcon Laboratories, Inc. | Angiostatic steroids |
CN1157404C (en) * | 1999-10-15 | 2004-07-14 | 里奥药物制品有限公司 | Novel fusidic acid derivatives |
US6395721B1 (en) | 2000-01-05 | 2002-05-28 | Leonard Bloom | Low potency unpreserved sterile topical corticosteroid compositions for dermatitis |
JP4619786B2 (en) * | 2002-08-29 | 2011-01-26 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | 3- (Sulfonamidoethyl) -indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases |
JP2005008596A (en) * | 2003-06-20 | 2005-01-13 | Kobayashi Pharmaceut Co Ltd | Ophthalmological composition |
CA2562356A1 (en) * | 2004-04-08 | 2005-10-27 | Retmed Pty Ltd | Treatment of ophthalmic conditions with mineralcorticoids |
WO2006017347A2 (en) * | 2004-07-12 | 2006-02-16 | Allergan, Inc. | Opthalmic compositions and methods for treating ophthalmic conditions |
US7687484B2 (en) * | 2006-05-25 | 2010-03-30 | Bodor Nicholas S | Transporter enhanced corticosteroid activity |
US7691811B2 (en) * | 2006-05-25 | 2010-04-06 | Bodor Nicholas S | Transporter-enhanced corticosteroid activity and methods and compositions for treating dry eye |
EP2319517B1 (en) * | 2006-06-01 | 2013-09-11 | Novagali Pharma S.A. | Use of prodrugs for ocular intravitreous administration |
ES2493641T3 (en) * | 2007-06-28 | 2014-09-12 | Cydex Pharmaceuticals, Inc. | Nasal administration of aqueous corticosteroid solutions |
JP2009053880A (en) | 2007-08-27 | 2009-03-12 | Sony Broadband Solution Corp | Information processor and cpu unit |
AR069804A1 (en) * | 2007-12-21 | 2010-02-17 | Schering Corp | GLUCOCORTICOID RECEIVER AGONISTS C20- C21 REPLACED |
CN105147608B (en) * | 2008-06-26 | 2019-12-10 | 安特里奥公司 | Dermal delivery |
UA111867C2 (en) | 2011-11-11 | 2016-06-24 | Аллерган, Інк. | PHARMACEUTICAL COMPOSITION AND METHOD OF APPLICATION OF 4-PROGEN-11β-17-21-TRIOL-3,20-DION DERIVATIVES |
-
2012
- 2012-09-11 UA UAA201406457A patent/UA111867C2/en unknown
- 2012-09-11 UA UAA201406244A patent/UA116622C2/en unknown
- 2012-11-09 MX MX2014005679A patent/MX365859B/en active IP Right Grant
- 2012-11-09 JP JP2014541293A patent/JP6158201B2/en not_active Expired - Fee Related
- 2012-11-09 CN CN201280065948.4A patent/CN104203247B/en not_active Expired - Fee Related
- 2012-11-09 US US13/673,074 patent/US8865691B2/en not_active Expired - Fee Related
- 2012-11-09 KR KR1020147015650A patent/KR20140095549A/en active IP Right Grant
- 2012-11-09 MX MX2014005678A patent/MX363669B/en unknown
- 2012-11-09 RU RU2014123472A patent/RU2688159C2/en not_active IP Right Cessation
- 2012-11-09 SG SG10201603766PA patent/SG10201603766PA/en unknown
- 2012-11-09 EP EP12787336.2A patent/EP2776040B1/en active Active
- 2012-11-09 IN IN3903CHN2014 patent/IN2014CN03903A/en unknown
- 2012-11-09 JP JP2014541292A patent/JP6216719B2/en not_active Expired - Fee Related
- 2012-11-09 RU RU2014123471A patent/RU2683775C2/en not_active IP Right Cessation
- 2012-11-09 MY MYPI2014001373A patent/MY172227A/en unknown
- 2012-11-09 WO PCT/US2012/064293 patent/WO2013071009A1/en active Application Filing
- 2012-11-09 SG SG11201402247PA patent/SG11201402247PA/en unknown
- 2012-11-09 BR BR112014011341A patent/BR112014011341A2/en not_active Application Discontinuation
- 2012-11-09 BR BR112014011333A patent/BR112014011333B1/en not_active IP Right Cessation
- 2012-11-09 TW TW101141986A patent/TWI584809B/en not_active IP Right Cessation
- 2012-11-09 CA CA2855929A patent/CA2855929C/en not_active Expired - Fee Related
- 2012-11-09 IN IN3919CHN2014 patent/IN2014CN03919A/en unknown
- 2012-11-09 CN CN201280066021.2A patent/CN104185472B/en not_active Expired - Fee Related
- 2012-11-09 ES ES12787336T patent/ES2806603T3/en active Active
- 2012-11-09 KR KR1020147015647A patent/KR102049615B1/en active IP Right Grant
- 2012-11-09 CA CA2855290A patent/CA2855290C/en not_active Expired - Fee Related
- 2012-11-09 AU AU2012335590A patent/AU2012335590B2/en not_active Ceased
- 2012-11-09 MY MYPI2014001372A patent/MY182222A/en unknown
- 2012-11-09 CA CA2991883A patent/CA2991883C/en not_active Expired - Fee Related
- 2012-11-09 SG SG11201402225RA patent/SG11201402225RA/en unknown
- 2012-11-09 US US13/673,623 patent/US8906892B2/en not_active Expired - Fee Related
- 2012-11-09 EP EP12787337.0A patent/EP2776041A1/en not_active Withdrawn
- 2012-11-09 WO PCT/US2012/064296 patent/WO2013071010A1/en active Application Filing
- 2012-11-09 AU AU2012335589A patent/AU2012335589B2/en not_active Ceased
- 2012-11-12 AR ARP120104261A patent/AR088846A1/en unknown
-
2014
- 2014-05-09 MX MX2019006877A patent/MX2019006877A/en unknown
- 2014-05-09 PH PH12014501079A patent/PH12014501079B1/en unknown
- 2014-05-09 PH PH12014501078A patent/PH12014501078B1/en unknown
- 2014-05-11 IL IL232535A patent/IL232535B/en active IP Right Grant
- 2014-05-11 IL IL232534A patent/IL232534A0/en active IP Right Grant
- 2014-05-12 CL CL2014001244A patent/CL2014001244A1/en unknown
- 2014-05-12 CL CL2014001243A patent/CL2014001243A1/en unknown
- 2014-05-13 ZA ZA2014/03431A patent/ZA201403431B/en unknown
- 2014-05-13 ZA ZA2014/03430A patent/ZA201403430B/en unknown
- 2014-05-29 CO CO14116546A patent/CO6970598A2/en unknown
- 2014-06-09 CO CO14124183A patent/CO6970609A2/en unknown
- 2014-09-12 US US14/485,335 patent/US9717743B2/en not_active Expired - Fee Related
- 2014-11-05 US US14/533,847 patent/US9433631B2/en active Active
-
2015
- 2015-01-31 HK HK15101081.1A patent/HK1200367A1/en unknown
- 2015-01-31 HK HK15101080.2A patent/HK1200366A1/en unknown
-
2016
- 2016-08-04 US US15/228,674 patent/US10493082B2/en not_active Expired - Fee Related
-
2017
- 2017-06-30 US US15/640,093 patent/US10188667B2/en not_active Expired - Fee Related
-
2018
- 2018-01-19 AU AU2018200436A patent/AU2018200436B2/en not_active Ceased
- 2018-12-24 US US16/231,901 patent/US20190365786A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014CN03903A (en) | ||
PH12015501738A1 (en) | Androgen receptor modulators and uses thereof | |
PH12014502095A1 (en) | Estrogen receptor modulators and uses thereof | |
PH12014501351A1 (en) | Fluorinated estrogen receptor modulators and uses thereof | |
MY180903A (en) | C17-alkanediyl and alkenediyl derivatives of oleanolic acid and methods of use thereof | |
NZ705213A (en) | C17-heteroaryl derivatives of oleanolic acid and methods of use thereof | |
IN2012DN05125A (en) | ||
IN2014MN01672A (en) | ||
MX357504B (en) | A phenyl triazole derivative and its use for modulating the gabaa receptor complex. | |
MX2019011265A (en) | Azaindole acetic acid derivatives and their use as prostaglandin d2 receptor modulators. | |
IN2015MN00421A (en) | ||
MX336578B (en) | N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS. | |
MX2016011900A (en) | Azaindole acetic acid derivatives and their use as prostaglandin d2 receptor modulators. | |
MX2013005169A (en) | Substituted bicyclic carboxamide and urea derivatives as vanilloid receptor ligands. | |
TN2011000518A1 (en) | Fused imidazole carboxamides as trpv3 modulators | |
TN2011000517A1 (en) | Fused pyrimidineone compounds as trpv3 modulators | |
TN2011000523A1 (en) | Chromenone derivatives as trpv3 antagonists | |
TN2011000520A1 (en) | Chromane derivatives as trpv3 modulators | |
TN2011000522A1 (en) | Chromenone derivatives as trpv3 modulators | |
TN2011000519A1 (en) | Fused imidazole derivatives as trpv3 antagonist |